Structure |
Chemical Name |
CAS |
MF |
![DibroMo IMpurity](/CAS/20180808/GIF/1352492-08-0.gif) |
DibroMo IMpurity |
1352492-08-0 |
C15H12Br2O2 |
![ErtapeneM IMpurity DIPP](/CAS/20200611/GIF/220031-86-7.gif) |
ErtapeneM IMpurity DIPP |
220031-86-7 |
C18H27N2O6PS |
![Gefitinib IMpurity 1](/CAS/20211123/GIF/1561173-24-7.gif) |
Gefitinib IMpurity 1 |
1561173-24-7 |
C15H22ClN3O3 |
![Pitavastatin Defuoro IMpurity CalciuM Salt](/CAS/20180808/GIF/1258947-30-6.gif) |
Pitavastatin Defuoro IMpurity CalciuM Salt |
1258947-30-6 |
C50H50CaN2O8 |
![Solifenacin Related CoMpound 4 Succinate](/CAS/20180808/GIF/862207-71-4.gif) |
Solifenacin Related CoMpound 4 Succinate |
862207-71-4 |
C27H32N2O6 |
![TenoxicaM IMpurity E (2-Methylthieno[2,3-d]isothiazol-3(2H)-one-1,1-dioxide )](/CAS/20150408/GIF/94040-09-2.gif) |
TenoxicaM IMpurity E (2-Methylthieno[2,3-d]isothiazol-3(2H)-one-1,1-dioxide ) |
94040-09-2 |
C6H5NO3S2 |
![(+)-ジヒドロビンポセチン](/CAS/20180808/GIF/57517-54-1.gif) |
(+)-ジヒドロビンポセチン |
57517-54-1 |
C22H28N2O2 |
![D,L-Venlafaxine-d10 Hydrochloride](/CAS/20150408/GIF/1216539-56-8.gif) |
D,L-Venlafaxine-d10 Hydrochloride |
1216539-56-8 |
C17H28ClNO2 |
![Ceritinib IMpurity](/) |
Ceritinib IMpurity |
|
|
![Melphalan IMpurity](/) |
Melphalan IMpurity |
|
|
![1-[2-[(5-chloro-2,4-diMethylphenyl)thio]phenyl]- Piperazine](/CAS/20150408/GIF/1240670-87-4.gif) |
1-[2-[(5-chloro-2,4-diMethylphenyl)thio]phenyl]- Piperazine |
1240670-87-4 |
C18H21ClN2S |
![4-(4-(4-(4-(((3S,5S)-5-((1H-1,2,4-triazol-1-yl)Methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)Methoxy)phenyl)piperazin-1-yl)phenyl)-1-((2R,3R)-2-hydroxypentan-3-yl)-1H-1,2,4-triazol-5(4H)-one](/CAS/20150408/GIF/CB22716057.gif) |
4-(4-(4-(4-(((3S,5S)-5-((1H-1,2,4-triazol-1-yl)Methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)Methoxy)phenyl)piperazin-1-yl)phenyl)-1-((2R,3R)-2-hydroxypentan-3-yl)-1H-1,2,4-triazol-5(4H)-one |
2243785-97-7 |
C37H42F2N8O4 |
![4-(4-broMo-3-(hydroxyMethyl)phenoxy)benzonitrile](/CAS/20150408/GIF/906673-45-8.gif) |
4-(4-broMo-3-(hydroxyMethyl)phenoxy)benzonitrile |
906673-45-8 |
C14H10BrNO2 |
![ACT 080803](/CAS/20180906/GIF/1433875-21-8.gif) |
ACT 080803 |
1433875-21-8 |
C16H13Br2N5O2 |
![L-Alanine, N-[(S)-hydroxyphenoxyphosphinyl]-, 1-Methylethyl ester, (P→3'),(P'→5')-diester with (2'R)-2'-deoxy-2'-fluoro-2'-Methyluridine](/CAS/20180808/GIF/1337482-17-3.gif) |
L-Alanine, N-[(S)-hydroxyphenoxyphosphinyl]-, 1-Methylethyl ester, (P→3'),(P'→5')-diester with (2'R)-2'-deoxy-2'-fluoro-2'-Methyluridine |
1337482-17-3 |
C34H45FN4O13P2 |
![Pyrido[2,3-d]pyriMidin-7(8H)-one, 2,6-dibroMo-8-cyclopentyl-5-Methyl-](/CAS/20150408/GIF/1415560-29-0.gif) |
Pyrido[2,3-d]pyriMidin-7(8H)-one, 2,6-dibroMo-8-cyclopentyl-5-Methyl- |
1415560-29-0 |
C13H13Br2N3O |
![1,1'-[1,3-Propanediylbis(oxy)]bis[2,5-dimethylbenzene]](/CAS/20150408/GIF/415724-02-6.gif) |
1,1'-[1,3-Propanediylbis(oxy)]bis[2,5-dimethylbenzene] |
415724-02-6 |
C19H24O2 |
![1-Dimethylamino-2-phenylbutan-2-yl 3,4,5-trimethoxybenzoate](/CAS/20150408/GIF/92414-09-0.gif) |
1-Dimethylamino-2-phenylbutan-2-yl 3,4,5-trimethoxybenzoate |
92414-09-0 |
C22H29NO5 |
![ヒドロキシチオバルデナフィル](/CAS/GIF/912576-30-8.gif) |
ヒドロキシチオバルデナフィル |
912576-30-8 |
C23H32N6O4S2 |
![(((((1-(6-aMino-9H-purin-9-yl)propan-2-yl)oxy)Methyl)phosphoryl)bis(oxy))bis(Methylene) isopropyl Methyl dicarbonate](/CAS/20150408/GIF/1246812-43-0.gif) |
(((((1-(6-aMino-9H-purin-9-yl)propan-2-yl)oxy)Methyl)phosphoryl)bis(oxy))bis(Methylene) isopropyl Methyl dicarbonate |
1246812-43-0 |
C17H26N5O10P |
![6-アミノ-2-エトキシアクリジン-9(10H)-オン](/CAS/20150408/GIF/144335-20-6.gif) |
6-アミノ-2-エトキシアクリジン-9(10H)-オン |
144335-20-6 |
C15H14N2O2 |
![parecoxib impurity L](/) |
parecoxib impurity L |
|
|
![Rupatadine iMpurity](/CAS/20210305/GIF/169253-15-0.gif) |
Rupatadine iMpurity |
169253-15-0 |
C19H19ClN2 |
![ceftazidiMe iMpurity C](/) |
ceftazidiMe iMpurity C |
|
|
![pidotiMod iMpurity E](/CAS/20150408/GIF/162148-16-5.gif) |
pidotiMod iMpurity E |
162148-16-5 |
C9H12N2O4S |
![4-[3-(トリフルオロメチル)-5-(o-トリル)-1H-ピラゾール-1-イル]ベンゼンスルホンアミド](/CAS/20180808/GIF/170569-99-0.gif) |
4-[3-(トリフルオロメチル)-5-(o-トリル)-1H-ピラゾール-1-イル]ベンゼンスルホンアミド |
170569-99-0 |
C17H14F3N3O2S |
![EMpagliflozin iMpurity 6](/CAS/20210111/GIF/1620758-21-5.gif) |
EMpagliflozin iMpurity 6 |
1620758-21-5 |
C32H37ClO12 |
![1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic acid,10-[2,3-dihydroxy-1-(hydroxymethyl)propyl]-](/CAS/20180629/GIF/138168-36-2.gif) |
1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic acid,10-[2,3-dihydroxy-1-(hydroxymethyl)propyl]- |
138168-36-2 |
C18H34N4O9 |
![ジ-ノルブデソニド(MIXTURE OF DIASTEREOMERS)](/CAS/20180808/GIF/1040085-98-0.gif) |
ジ-ノルブデソニド(MIXTURE OF DIASTEREOMERS) |
1040085-98-0 |
C23H30O6 |
![Linagliptin MethyldiMer](/CAS/20180808/GIF/1418133-47-7.gif) |
Linagliptin MethyldiMer |
1418133-47-7 |
C50H56N16O4 |
![Trelagliptin Impurity isomer](/CAS/20210111/GIF/2206135-35-3.gif) |
Trelagliptin Impurity isomer |
2206135-35-3 |
C18H20FN5O2 |
![(2R,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(hydroxyMethyl)tetrahydro-2H-pyran-3,4,5-triol](/CAS/20150408/GIF/CB22731179.gif) |
(2R,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(hydroxyMethyl)tetrahydro-2H-pyran-3,4,5-triol |
|
C21H25ClO6 |
![3,6-ジクロロピラジン-2-カルボキサミド](/CAS/20150408/GIF/1023813-21-9.gif) |
3,6-ジクロロピラジン-2-カルボキサミド |
1023813-21-9 |
C5H3Cl2N3O |
![2-((3-ヒドロキシアダマンタン-1-イル)アミノ)酢酸](/CAS/20180713/GIF/1032564-18-3.gif) |
2-((3-ヒドロキシアダマンタン-1-イル)アミノ)酢酸 |
1032564-18-3 |
C12H19NO3 |
![9(10H)-Acridinone, 2-ethoxy-6-nitro-](/CAS/20150408/GIF/451460-48-3.gif) |
9(10H)-Acridinone, 2-ethoxy-6-nitro- |
451460-48-3 |
C15H12N2O4 |
![Olaparib iMpurity D](/) |
Olaparib iMpurity D |
|
|
![(5-broMo-2-chlorophenyl)(4-hydroxyphenyl)Methanone](/CAS/20150408/GIF/1360568-68-8.gif) |
(5-broMo-2-chlorophenyl)(4-hydroxyphenyl)Methanone |
1360568-68-8 |
C13H8BrClO2 |
![(2-broMo-4,5-diMethylphenyl)Methanol](/CAS/20150408/GIF/1126385-20-3.gif) |
(2-broMo-4,5-diMethylphenyl)Methanol |
1126385-20-3 |
C9H11BrO |
![Posaconazole iMpurity 8](/) |
Posaconazole iMpurity 8 |
|
|
![Dehydro Benidipine](/CAS/20200515/GIF/118935-44-7.gif) |
Dehydro Benidipine |
118935-44-7 |
C28H29N3O6 |
![Etoposide Impurity B](/CAS/20180808/GIF/100007-56-5.gif) |
Etoposide Impurity B |
100007-56-5 |
C29H32O13 |
![Istradefylline Impurity 2](/CAS/20180906/GIF/606080-73-3.gif) |
Istradefylline Impurity 2 |
606080-73-3 |
C20H24N4O4 |
![Oxonic Acid Impurity 1](/CAS/20200611/GIF/60301-55-5.gif) |
Oxonic Acid Impurity 1 |
60301-55-5 |
C3H3N3O2 |
![Vortioxetine Impurity 4](/CAS/20180906/GIF/1293489-77-6.gif) |
Vortioxetine Impurity 4 |
1293489-77-6 |
C18H22N2S |
![Zidovudine USP Impurity G](/CAS/20180808/GIF/148665-49-0.gif) |
Zidovudine USP Impurity G |
148665-49-0 |
C20H25N7O8 |
![Quinoline, 6,7-dimethoxy-4-(4-nitrophenoxy)-](/CAS/20180629/GIF/190728-24-6.gif) |
Quinoline, 6,7-dimethoxy-4-(4-nitrophenoxy)- |
190728-24-6 |
C17H14N2O5 |
![Itopride Impurity A](/CAS/20210111/GIF/943518-63-6.gif) |
Itopride Impurity A |
943518-63-6 |
C16H17NO4 |
![ナトリウム1-メチル-1H-テトラゾール-5-チオラート](/CAS/GIF/51138-06-8.gif) |
ナトリウム1-メチル-1H-テトラゾール-5-チオラート |
51138-06-8 |
C2H3N4NaS |
![2-[[[3-メチル-4-(2,2,2-トリフルオロエトキシ)-2-ピリジニル]メチル]スルフィニル]-1H-ベンゾイミダゾール-5-オール](/CAS/GIF/131926-98-2.gif) |
2-[[[3-メチル-4-(2,2,2-トリフルオロエトキシ)-2-ピリジニル]メチル]スルフィニル]-1H-ベンゾイミダゾール-5-オール |
131926-98-2 |
C16H14F3N3O3S |
![Ticagrelor Impurity N](/CAS/20200515/GIF/1643378-47-5.gif) |
Ticagrelor Impurity N |
1643378-47-5 |
C23H29FN6O4S |
![N-[(1R,2R,5S)-5-(ジメチルカルバモイル)-2-ヒドロキシシクロヘキシル]カルバミン酸TERT-ブチル](/CAS/20200331/GIF/929693-30-1.gif) |
N-[(1R,2R,5S)-5-(ジメチルカルバモイル)-2-ヒドロキシシクロヘキシル]カルバミン酸TERT-ブチル |
929693-30-1 |
C14H26N2O4 |
![Valaciclovir iMpurity](/) |
Valaciclovir iMpurity |
|
|
![Sunitinib Impurity 5](/) |
Sunitinib Impurity 5 |
|
|
![Silodosin Impurity 6](/) |
Silodosin Impurity 6 |
|
|
![1H-Pyrazole-1-propanenitrile, β-cyclopentyl-4-[7-(hydroxyMethyl)-7H-pyrrolo[2,3-d]pyriMidin-4-yl]-,(βR)-](/CAS/20180808/GIF/1236033-03-6.gif) |
1H-Pyrazole-1-propanenitrile, β-cyclopentyl-4-[7-(hydroxyMethyl)-7H-pyrrolo[2,3-d]pyriMidin-4-yl]-,(βR)- |
1236033-03-6 |
C18H20N6O |
![Cyclopropanecarboxylic acid, 1-[(phenylaMino)carbonyl]-](/CAS/20150408/GIF/145591-80-6.gif) |
Cyclopropanecarboxylic acid, 1-[(phenylaMino)carbonyl]- |
145591-80-6 |
C11H11NO3 |
![3-PiperidinaMine, 1-acetyl-N,4-diMethyl-N-1H-pyrrolo[2,3-d]pyriMidin-4-yl-, (3R,4R)- (9CI)](/CAS/20150408/GIF/477600-76-3.gif) |
3-PiperidinaMine, 1-acetyl-N,4-diMethyl-N-1H-pyrrolo[2,3-d]pyriMidin-4-yl-, (3R,4R)- (9CI) |
477600-76-3 |
C15H21N5O |
![MeropeneM iMpurity](/CAS/20210111/GIF/96035-23-3.gif) |
MeropeneM iMpurity |
96035-23-3 |
C15H19N3O5S |
![デスフルオロシプロフロキサシン](/CAS/20150408/GIF/93107-11-0.gif) |
デスフルオロシプロフロキサシン |
93107-11-0 |
C17H19N3O3 |
![Valdecoxib IMpurity-E](/CAS/20150408/GIF/1373038-63-1.gif) |
Valdecoxib IMpurity-E |
1373038-63-1 |
C16H11Cl2NO5S2 |
![Sunitinib N-Oxide](/CAS/20180808/GIF/356068-99-0.gif) |
Sunitinib N-Oxide |
356068-99-0 |
C22H27FN4O3 |
![BendaMustine IMpurity D BendaMustine N-Alkylated IMpurity](/) |
BendaMustine IMpurity D BendaMustine N-Alkylated IMpurity |
|
|
![Cefradine IMpurity E](/) |
Cefradine IMpurity E |
|
|
![Erlotinib Impurity 19](/) |
Erlotinib Impurity 19 |
|
|
![Ticagrelor Impurity 40](/) |
Ticagrelor Impurity 40 |
|
|
![Moxifloxacin Impurity 12](/) |
Moxifloxacin Impurity 12 |
|
|
![Cabozantinib Impurity 4](/) |
Cabozantinib Impurity 4 |
|
|
![Lenvatinib Impurity 35](/) |
Lenvatinib Impurity 35 |
|
|
![Febuxostat Impurity 58](/) |
Febuxostat Impurity 58 |
|
|
![Cefodizime Impurity B](/) |
Cefodizime Impurity B |
|
|
![Cefodizime Impurity D](/) |
Cefodizime Impurity D |
|
|
![Penicillin Impurity B](/) |
Penicillin Impurity B |
|
|
![4,4'-(1H-1,2,4-Triazol-1-ylmethylene)bis[benzoic acid]](/CAS/20200401/GIF/1644566-39-1.gif) |
4,4'-(1H-1,2,4-Triazol-1-ylmethylene)bis[benzoic acid] |
1644566-39-1 |
C17H13N3O4 |
![Cefminox Sodium impurity B](/) |
Cefminox Sodium impurity B |
|
|
![Cefotiam Impurity B](/) |
Cefotiam Impurity B |
|
|
![pranoprofen impurity 11](/CAS/20210111/GIF/52549-44-7.gif) |
pranoprofen impurity 11 |
52549-44-7 |
C15H13NO4 |
![Cefazolin Impurity 5](/) |
Cefazolin Impurity 5 |
|
|
![Peramivir Impurity E](/) |
Peramivir Impurity E |
|
|
![Lincomycin sulfoxide Impurity 3](/) |
Lincomycin sulfoxide Impurity 3 |
|
|
![Lincomycin sulfoxide Impurity F](/) |
Lincomycin sulfoxide Impurity F |
|
|
![Fasudil iMpurity F](/) |
Fasudil iMpurity F |
|
|
![1-cyclopropyl-8-ethoxy-6-fluoro-7-((4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid hydrochloride](/CAS/20200401/GIF/2252446-70-9.gif) |
1-cyclopropyl-8-ethoxy-6-fluoro-7-((4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid hydrochloride
|
2252446-70-9 |
C22H27ClFN3O4 |
![Doxofylline iMpurity E](/) |
Doxofylline iMpurity E |
|
|
![Mupirocin Impurity 3](/CAS/20200401/GIF/CB84943000.gif) |
Mupirocin Impurity 3 |
|
C26H44O9 |
![3,4-DICHLOROBENZYLAMINE HYDROCHLORIDE](/CAS/GIF/49552-34-3.gif) |
3,4-DICHLOROBENZYLAMINE HYDROCHLORIDE |
49552-34-3 |
C7H8Cl3N |
![(S)-3-メチル-1-(2-ピペリジン-1-イルフェニル)ブチルアミン](/CAS/GIF/147769-93-5.gif) |
(S)-3-メチル-1-(2-ピペリジン-1-イルフェニル)ブチルアミン |
147769-93-5 |
C16H26N2 |
![ジフェノキノン](/CAS/GIF/494-72-4.gif) |
ジフェノキノン |
494-72-4 |
C12H8O2 |
![S-(+)-O-DESMETHYL VENLAFAXINE](/CAS/GIF/142761-12-4.gif) |
S-(+)-O-DESMETHYL VENLAFAXINE |
142761-12-4 |
C16H25NO2 |
![シンバスタチンアセアート](/CAS/GIF/145576-25-6.gif) |
シンバスタチンアセアート |
145576-25-6 |
C27H40O6 |
![5-(4'-メチル-2-ビフェニル)テトラゾール](/CAS/GIF/120568-11-8.gif) |
5-(4'-メチル-2-ビフェニル)テトラゾール |
120568-11-8 |
C14H12N4 |
![(2S)-2-アミノブチルアミド](/CAS/GIF/7324-11-0.gif) |
(2S)-2-アミノブチルアミド |
7324-11-0 |
C4H10N2O |
![Dihydro-Simvastatin](/CAS/20200401/GIF/92083-03-9.gif) |
Dihydro-Simvastatin |
92083-03-9 |
C25H40O5 |
![Ceftriaxone Sodium impurity 3](/) |
Ceftriaxone Sodium impurity 3 |
|
|
![Sugammadex sodium Monoiodo Impurity](/) |
Sugammadex sodium Monoiodo Impurity |
|
|
![(3S,4R)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-1-methyl-4-phenylpiperidine](/CAS/20200401/GIF/CB85422885.gif) |
(3S,4R)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-1-methyl-4-phenylpiperidine |
|
C20H23NO3 |
![176760-99-9](/CAS/20200611/GIF/176760-99-9.gif) |
176760-99-9 |
176760-99-9 |
C17H13FN2O4 |
![NILOTINIB IMPURITY 17](/CAS/20210111/GIF/851137-91-2.gif) |
NILOTINIB IMPURITY 17 |
851137-91-2 |
C17H15N5O |
![DexMedetoMidine IMpurity 16](/) |
DexMedetoMidine IMpurity 16 |
|
|
![Canagliflozin Impurity 2](/) |
Canagliflozin Impurity 2 |
2952941-15-8 |
|
![Rivaroxaban Impurity 22](/) |
Rivaroxaban Impurity 22 |
|
|